Download PDF
Neuropediatrics
DOI: 10.1055/a-2541-8620
Original Article

Intraventricular Application of Baclofen Using Navigated Frameless Stereotaxy: A Technical Note

Maria Abel
1   Department of Neurosurgery and Epilepsy Surgery, Spine and Scoliosis Surgery, Schoen Clinic Vogtareuth, Vogtareuth, Germany
,
Manfred Kudernatsch
1   Department of Neurosurgery and Epilepsy Surgery, Spine and Scoliosis Surgery, Schoen Clinic Vogtareuth, Vogtareuth, Germany
2   Research Institute “Rehabilitation, Transition, Palliation,” PMU Salzburg, Salzburg, Austria
,
Sergey Persits
1   Department of Neurosurgery and Epilepsy Surgery, Spine and Scoliosis Surgery, Schoen Clinic Vogtareuth, Vogtareuth, Germany
,
Christina Onyinzo
1   Department of Neurosurgery and Epilepsy Surgery, Spine and Scoliosis Surgery, Schoen Clinic Vogtareuth, Vogtareuth, Germany
,
Thomas Herberhold
3   Department of Pediatric Neurology, Neurorehabilitation and Epileptology, Schoen Clinic Vogtareuth, Vogtareuth, Germany
,
Till Hartlieb
2   Research Institute “Rehabilitation, Transition, Palliation,” PMU Salzburg, Salzburg, Austria
3   Department of Pediatric Neurology, Neurorehabilitation and Epileptology, Schoen Clinic Vogtareuth, Vogtareuth, Germany
,
Gerhard Kluger
2   Research Institute “Rehabilitation, Transition, Palliation,” PMU Salzburg, Salzburg, Austria
3   Department of Pediatric Neurology, Neurorehabilitation and Epileptology, Schoen Clinic Vogtareuth, Vogtareuth, Germany
,
Steffen Berweck
3   Department of Pediatric Neurology, Neurorehabilitation and Epileptology, Schoen Clinic Vogtareuth, Vogtareuth, Germany
4   Dr. von Hauners Children's Hospital, Munich University, Munich, Germany
› Author Affiliations Funding None.
› Further Information
Also available at
    Permissions and Reprints

Abstract

Objective

The spinal application of intrathecal baclofen (ITB) has been commonly used as treatment for severe dystonia as well spasticity. However, in rare cases, the use of ITB is not possible or ineffective. Therefore, intraventricular application of baclofen (IVB) mostly using endoscopic navigation has been rarely performed over the last years. As a valid alternative, we introduced navigated frameless stereotaxy for intraventricular catheter placement as the most minimally invasive approach feasible.

Methods

We retrospectively report on surgical technique, clinical outcome, and long-term complications in all pediatric patients with severe generalized dystonia who received IVB using navigated frameless stereotaxy between April 2009 and June 2021 at our institution.

Results

Twenty patients (median age: 13 years; range: 2–23 years) were treated with IVB. Dystonia improved in 19/20 patients at the time of discharge (median 51 days; range 2–93 weeks). During the follow-up period (median: 19 months; range: 3–83 months), there was a total of five surgery-associated complications including 3/20 pump infections and 2/20 intraventricular catheter dislocations.

Conclusion

This study reveals that navigated frameless catheter positioning in IVB therapy of generalized dystonia is a comparatively low risk and effective surgical procedure.

Keywords

dystonia - intraventricular baclofen - navigated frameless stereotaxy


Publication History

Received: 08 September 2024

Accepted: 18 February 2025

Article published online:
05 March 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • References

  • 1 Albright AL. Intrathecal baclofen in cerebral palsy movement disorders. J Child Neurol 1996; 11 (Suppl. 01) S29-S35
    CrossrefPubMedSearch in Google Scholar
  • 2 Biering-Soerensen B, Stevenson V, Bensmail D. et al. European expert consensus on improving patient selection for the management of disabling spasticity with intrathecal baclofen and/or botulinum toxin type A. J Rehabil Med 2022; 54: jrm00241
    PubMedSearch in Google Scholar
  • 3 Porter B. A review of intrathecal baclofen in the management of spasticity. Br J Nurs 1997; 6 (05) 253-260 , 262
    CrossrefPubMedSearch in Google Scholar
  • 4 Monbaliu E, Himmelmann K, Lin JP. et al. Clinical presentation and management of dyskinetic cerebral palsy. Lancet Neurol 2017; 16 (09) 741-749
    CrossrefPubMedSearch in Google Scholar
  • 5 Fehlings D, Brown L, Harvey A. et al. Pharmacological and neurosurgical interventions for managing dystonia in cerebral palsy: a systematic review. Dev Med Child Neurol 2018; 60 (04) 356-366
    CrossrefPubMedSearch in Google Scholar
  • 6 Tsering D, Tochen L, Lavenstein B. et al. Considerations in deep brain stimulation (DBS) for pediatric secondary dystonia. Childs Nerv Syst 2017; 33 (04) 631-637
    CrossrefPubMedSearch in Google Scholar
  • 7 Albright AL, Barry MJ, Shafton DH, Ferson SS. Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol 2001; 43 (10) 652-657
    CrossrefPubMedSearch in Google Scholar
  • 8 Albright AL, Ferson SS. Intraventricular baclofen for dystonia: techniques and outcomes. Clinical article. J Neurosurg Pediatr 2009; 3 (01) 11-14
    CrossrefPubMedSearch in Google Scholar
  • 9 Albright AL, Barry MJ, Painter MJ, Shultz B. Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy. J Neurosurg 1998; 88 (01) 73-76
    CrossrefPubMedSearch in Google Scholar
  • 10 Penn RD, Gianino JM, York MM. Intrathecal baclofen for motor disorders. Mov Disord 1995; 10 (05) 675-677
    CrossrefPubMedSearch in Google Scholar
  • 11 Walker RH, Danisi FO, Swope DM, Goodman RR, Germano IM, Brin MF. Intrathecal baclofen for dystonia: benefits and complications during six years of experience. Mov Disord 2000; 15 (06) 1242-1247
    CrossrefPubMedSearch in Google Scholar
  • 12 Bonouvrié LA, Becher JG, Vles JSH, Vermeulen RJ, Buizer AI, Group IS. IDYS Study Group. The effect of intrathecal baclofen in dyskinetic cerebral palsy: the IDYS Trial. Ann Neurol 2019; 86 (01) 79-90
    CrossrefPubMedSearch in Google Scholar
  • 13 Motta F, Stignani C, Antonello CE. Effect of intrathecal baclofen on dystonia in children with cerebral palsy and the use of functional scales. J Pediatr Orthop 2008; 28 (02) 213-217
    CrossrefPubMedSearch in Google Scholar
  • 14 Bledsoe IO, Viser AC, San Luciano M. Treatment of dystonia: medications, neurotoxins, neuromodulation, and rehabilitation. Neurotherapeutics 2020; 17 (04) 1622-1644
    CrossrefPubMedSearch in Google Scholar
  • 15 Kim JH, Jung NY, Chang WS, Jung HH, Cho SR, Chang JW. Intrathecal baclofen pump versus globus pallidus interna deep brain stimulation in adult patients with severe cerebral palsy. World Neurosurg 2019; 126: e550-e556
    CrossrefPubMedSearch in Google Scholar
  • 16 Neychev VK, Gross RE, Lehéricy S, Hess EJ, Jinnah HA. The functional neuroanatomy of dystonia. Neurobiol Dis 2011; 42 (02) 185-201
    CrossrefPubMedSearch in Google Scholar
  • 17 Siebner HR, Dressnandt J, Auer C, Conrad B. Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia. Muscle Nerve 1998; 21 (09) 1209-1212
    CrossrefPubMedSearch in Google Scholar
  • 18 Narayan RK, Loubser PG, Jankovic J, Donovan WH, Bontke CF. Intrathecal baclofen for intractable axial dystonia. Neurology 1991; 41 (07) 1141-1142
    CrossrefPubMedSearch in Google Scholar
  • 19 Albright AL. Technique for insertion of intraventricular baclofen catheters. J Neurosurg Pediatr 2011; 8 (04) 394-395
    CrossrefPubMedSearch in Google Scholar
  • 20 Charlesworth G, Bhatia KP, Wood NW. The genetics of dystonia: new twists in an old tale. Brain 2013; 136 (Pt 7): 2017-2037
    CrossrefPubMedSearch in Google Scholar
  • 21 Jinnah HA. Medical and surgical treatments for dystonia. Neurol Clin 2020; 38 (02) 325-348
    CrossrefPubMedSearch in Google Scholar
  • 22 Fehlings D, Agnew B, Gimeno H. et al. Pharmacological and neurosurgical management of cerebral palsy and dystonia: clinical practice guideline update. Dev Med Child Neurol 2024; 66 (09) 1133-1147
    CrossrefPubMedSearch in Google Scholar
  • 23 Saenz A, Grijalba M, Mengide JP, Argañaraz R, Ford F, Mantese B. Baclofen pump with pre-brainstem catheter tip placement: technical note and case series. Childs Nerv Syst 2021; 37 (01) 203-210
    CrossrefPubMedSearch in Google Scholar
  • 24 Borowski A, Littleton AG, Borkhuu B. et al. Complications of intrathecal baclofen pump therapy in pediatric patients. J Pediatr Orthop 2010; 30 (01) 76-81
    CrossrefPubMedSearch in Google Scholar
  • 25 Haranhalli N, Anand D, Wisoff JH. et al. Intrathecal baclofen therapy: complication avoidance and management. Childs Nerv Syst 2011; 27 (03) 421-427
    CrossrefPubMedSearch in Google Scholar
  • 26 Motta F, Buonaguro V, Stignani C. The use of intrathecal baclofen pump implants in children and adolescents: safety and complications in 200 consecutive cases. J Neurosurg 2007; 107 (1, Suppl): 32-35
    PubMedSearch in Google Scholar
  • 27 Vender JR, Hester S, Waller JL, Rekito A, Lee MR. Identification and management of intrathecal baclofen pump complications: a comparison of pediatric and adult patients. J Neurosurg 2006; 104 (1, Suppl): 9-15
    PubMedSearch in Google Scholar
  • 28 Rocque BG, Leland Albright A. Intraventricular vs intrathecal baclofen for secondary dystonia: a comparison of complications. Neurosurgery 2012; 70 (2, Suppl Operative): 321-325 , discussion 325–326
    PubMedSearch in Google Scholar
  • 29 Imerci A, Rogers KJ, Pargas C, Sees JP, Miller F. Identification of complications in paediatric cerebral palsy treated with intrathecal baclofen pump: a descriptive analysis of 15 years at one institution. J Child Orthop 2019; 13 (05) 529-535
    CrossrefPubMedSearch in Google Scholar
  • 30 Berweck S, Lütjen S, Voss W. et al; ITB Working Party. Use of intrathecal baclofen in children and adolescents: interdisciplinary consensus table 2013. Neuropediatrics 2014; 45 (05) 294-308
    Thieme ConnectPubMedSearch in Google Scholar
  • 31 Sayer C, Lumsden DE, Perides S. et al. Intrathecal baclofen trials: complications and positive yield in a pediatric cohort. J Neurosurg Pediatr 2016; 17 (02) 240-245
    CrossrefPubMedSearch in Google Scholar